(113 days)
No
The description focuses on the mechanical aspects of the implant and instruments, with no mention of AI or ML capabilities.
Yes
The device is indicated for "fusion of the sacroiliac joint for sacroiliac joint dysfunction" and "fracture fixation of small and large bones of the pelvis," which are therapeutic interventions.
No
The device is described as an implant system for fusion and fracture fixation, not for diagnosing medical conditions.
No
The device description clearly outlines physical implants (iFuse-TORQ Implants) and associated instruments, which are hardware components. There is no mention of software being the primary or sole component of the device.
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Description: The iFuse-TORQ Implant System is described as implants and instruments used for surgical procedures (fusion of the sacroiliac joint and fracture fixation of pelvic bones). These are physical devices implanted into the body or used to facilitate implantation.
- Intended Use: The intended use clearly states surgical procedures for musculoskeletal issues, not diagnostic testing of biological samples.
- Lack of IVD Indicators: The text does not mention any of the typical characteristics of an IVD, such as analyzing biological samples, detecting biomarkers, or providing diagnostic information based on laboratory tests.
Therefore, the iFuse-TORQ Implant System is a surgical implant and instrument system, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The iFuse-TORQ™ Implant System is indicated for:
- Fusion of the sacroiliac joint for sacroiliac joint dysfunction including sacroiliac joint disruption and degenerative sacroiliitis.
- Fracture fixation of small and large bones of the pelvis
Product codes
OUR
Device Description
The iFuse-TORO Implant System consists of the iFuse-TORO Implants and associated Instruments which are included in two Instrument Sets: iFuse-TORQ Instrument Set and iFuse-TORQ Revision Instrument Set. The iFuse-TORQ Implant System is designed to provide a non-impacted, threaded solution for sacroiliac joint fusion, as well as compression across the SI joint, and for fracture fixation of small and large bones of the pelvis.
The iFuse-TORQ Implants are sterile, single use 3D-printed implants that are provided in various lengths and diameters, and feature flutes and multiple fenestrations along the shaft length (Table 1). The iFuse-TORO Implants are provided in two primary configurations – fully threaded and lag implant designs with optional washers. The cannulated implants include a tapered distal tip and dualsingle-dual lead threads that are compatible with off-the-shelf 3.2 mm guidewires. The iFuse-TORQ Implant designs allow for packing of autograft and allograft materials.
The iFuse-TORO Instruments are provided in two sets: iFuse-TORO Instrument Set (with Primary and Navigation Instruments) and the iFuse TORO Revision Instrument Set. The iFuse-TORO Instruments Sets consist of single use, disposable and reusable instruments. The instruments are provided non-sterile and are intended for cleaning and steam sterilization by the user prior to each use. The iFuse-TORQ Instruments consist of both Class II and Class I medical devices which facilitate the introduction, adjustment / positioning, final placement, and removal (if required) of the implants in the target anatomy.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Sacroiliac joint, pelvis
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Design verification and validation testing provided in the subject premarket notification, including Sterilization and Cleaning Validations, Packaging / Transit Validations, Shelf Life Assessment; Biocompatibility Assessment; and Bench Performance Testing, including MR Compatibility Assessment, as well as Simulated Use Testing, demonstrate that the iFuse-TORQ Implant System meets requirements of the product specification for its intended clinical use and is substantially equivalent to the predicate devices.
SI-BONE performed comprehensive Design Verification and Validation Testing to demonstrate the performance of SI-BONE's iFuse-TORQ Implant System for its intended clinical use (Table 2). Sterilization and Cleaning Validations, Packaging / Transit Validations, Shelf-Life Assessment; Biocompatibility Assessment; and Bench Performance Testing, including MR Compatibility Assessment, as well as Simulated Use Testing have been performed.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 888.3040 Smooth or threaded metallic bone fixation fastener.
(a)
Identification. A smooth or threaded metallic bone fixation fastener is a device intended to be implanted that consists of a stiff wire segment or rod made of alloys, such as cobalt-chromium-molybdenum and stainless steel, and that may be smooth on the outside, fully or partially threaded, straight or U-shaped; and may be either blunt pointed, sharp pointed, or have a formed, slotted head on the end. It may be used for fixation of bone fractures, for bone reconstructions, as a guide pin for insertion of other implants, or it may be implanted through the skin so that a pulling force (traction) may be applied to the skeletal system.(b)
Classification. Class II.
0
March 4, 2021
Image /page/0/Picture/1 description: The image contains the logos of the Department of Health and Human Services and the Food and Drug Administration (FDA). The Department of Health and Human Services logo is on the left, and the FDA logo is on the right. The FDA logo includes the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue text.
SI-BONE, Inc. Susan Noriega Sr. Director Regulatory Affairs 471 El Camino Real, Suite 101 Santa Clara, California 95050
Re: K203247
Trade/Device Name: iFuse-TORQ™ Implant System Regulation Number: 21 CFR 888.3040 Regulation Name: Smooth or threaded metallic bone fixation fastener Regulatory Class: Class II Product Code: OUR
Dear Susan Noriega:
The Food and Drug Administration (FDA) is sending this letter to notify you of an administrative change related to your previous substantial equivalence (SE) determination letter dated February 25, 2021. Specifically, FDA is updating this SE as an administrative correction due to a typographical error in the Indications for Use form.
Please note that the 510(k) submission was not re-reviewed. For questions regarding this letter please contact Colin O'Neill, M.B.E., OHT6: Office of Orthopedic Devices, (301) 796-6428, colin.oneill@fda.hhs.gov.
Sincerely,
Colin O'neill -S
Colin O'Neill, M.B.E. Assistant Director DHT6B: Division of Spinal Devices OHT6: Office of Orthopedic Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
1
February 25, 2021
Image /page/1/Picture/1 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
SI-BONE, Inc. Susan Noriega Sr. Director Regulatory Affairs 471 El Camino Real, Suite 101 Santa Clara, California 95050
Re: K203247
Trade/Device Name: iFuse-TORQ™ Implant System Regulation Number: 21 CFR 888.3040 Regulation Name: Smooth Or Threaded Metallic Bone Fixation Fastener Regulatory Class: Class II Product Code: OUR Dated: January 22, 2021 Received: January 25, 2021
Dear Susan Noriega:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for
2
devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely.
Colin O'neill -S
Colin O'Neill, M.B.E. Assistant Director DHT6B: Division of Spinal Devices OHT6: Office of Orthopedic Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
3
Indications for Use
510(k) Number (if known) K203247
Device Name iFuse-TORQTM Implant System
Indications for Use (Describe)
The iFuse-TORQ™ Implant System is indicated for:
· Fusion of the sacroiliac joint for sacroiliac joint dysfunction including sacroiliac joint disruption and degenerative sacroiliitis.
· Fracture fixation of small and large bones of the pelvis
| Type of Use (Select one or both, as applicable) |
|---|
| ------------------------------------------------- |
| Prescription Use (Part 21 CFR 801 Subpart D) |
|---|
| Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
4
Image /page/4/Picture/1 description: The image shows the logo for the iFuse Implant System. The logo consists of the words "SI-BONE" in bold black letters, with a green curved line above the "BONE" portion. To the right of "SI-BONE" are the words "iFuse Implant System" in bold black letters, with the words "Minimally Invasive Sacroiliac Joint Surgery" in smaller black letters below.
510(k) SUMMARY iFuse-TORQ™ Implant System
I. DATE PREPARED
February 22, 2021
II. 510(k) SUBMITTER
SI-BONE, Inc. 471 El Camino Real, Suite 101, Santa Clara, CA 95050 Phone: 408-207-0700 Fax: 408-557-8312
Contact Person: Susan Noriega, Sr. Director Regulatory Affairs
FDA Establishment Registration No.: 3007700286
III. DEVICE
| Trade Name of Device: | iFuse-TORQ TM Implant System |
|---|---|
| Common or Usual Name: | Sacroiliac Joint Fixation |
| Classification: | II |
| Regulation Number: | 21 CFR 888.3040; Smooth or threaded metallic bone |
| fastener Product Code: | OUR |
IV. PREDICATE DEVICES
| Primary Predicate Device | Manufacturer | 510(k)# | Clearance Date |
|---|---|---|---|
| M.U.S.T. Sacral Iliac Screw and | |||
| Pelvic Trauma System | Medacta International SA | K193083 | December 3, 2019 |
| Additional Predicate Devices | Manufacturer | 510(k)# | Clearance Date |
| iFuse-3D Implant System | SI-BONE, Inc. | K193524 | March 31, 2020 |
| Genesys Spine Sacroiliac Joint | |||
| Fusion System | Genesys Spine | K191748 | September 26, 2019 |
5
V. DEVICE DESCRIPTION
The iFuse-TORO Implant System consists of the iFuse-TORO Implants and associated Instruments which are included in two Instrument Sets: iFuse-TORQ Instrument Set and iFuse-TORQ Revision Instrument Set. The iFuse-TORQ Implant System is designed to provide a non-impacted, threaded solution for sacroiliac joint fusion, as well as compression across the SI joint, and for fracture fixation of small and large bones of the pelvis.
The iFuse-TORQ Implants are sterile, single use 3D-printed implants that are provided in various lengths and diameters, and feature flutes and multiple fenestrations along the shaft length (Table 1). The iFuse-TORO Implants are provided in two primary configurations – fully threaded and lag implant designs with optional washers. The cannulated implants include a tapered distal tip and dualsingle-dual lead threads that are compatible with off-the-shelf 3.2 mm guidewires. The iFuse-TORQ Implant designs allow for packing of autograft and allograft materials.
| Implants | Description |
|---|---|
| Fully Threaded Implant | |
| Models: | 100XXT, 115XXT, 135XXT* |
| Diameters: | Ø10.0 mm, Ø11.5 mm, Ø13.5 mm |
| Lengths: | 30 mm – 90 mm in 5 mm increments |
| Lag Implant | |
| Models: | 100XXLG, 115XXLG, 135XXLG |
| Diameters: | Ø10.0 mm (with optional 16mm washer), Ø11.5 mm (with |
| optional 18mm washer), Ø13.5 mm (with optional 18mm | |
| washer) | |
| Lengths: | 40 mm – 90 mm in 5 mm increments |
Table 1. iFuse-TORQ Implant Key Dimensions
*Note that XX represents length
The iFuse-TORO Instruments are provided in two sets: iFuse-TORO Instrument Set (with Primary and Navigation Instruments) and the iFuse TORO Revision Instrument Set. The iFuse-TORO Instruments Sets consist of single use, disposable and reusable instruments. The instruments are provided non-sterile and are intended for cleaning and steam sterilization by the user prior to each use. The iFuse-TORQ Instruments consist of both Class II and Class I medical devices which facilitate the introduction, adjustment / positioning, final placement, and removal (if required) of the implants in the target anatomy.
VI. INDICATIONS FOR USE
The iFuse-TORQ™ Implant System is indicated for:
- Fusion of the sacroiliac joint for sacroiliac joint dysfunction including sacroiliac joint disruption and . degenerative sacroiliitis
- . Fracture fixation of small and large bones of the pelvis
VII. SUMMARY OF SUBSTANTIAL EQUIVALENCE
The SI-BONE iFuse-TORQ Implant System has the same intended use, similar indications for use and technological characteristics as the FDA cleared Medacta International M.U.S.T. Sacral Iliac Screw and Pelvic Trauma System (most recently cleared in K193083 and K171595). The iFuse-TORO Implant is fabricated from similar materials, manufactured using similar processes, and utilizes similar cleaning and identical sterilization processes as the SI-BONE iFuse-3D Implant (most recently cleared in K193524 and in K162733). Additionally, the iFuse-TORQ Implant 3D-printed porous surface is based on similar 3D-printed technology used for the SI-BONE iFuse-3D Implant.
6
Design verification and validation testing provided in the subject premarket notification, including Sterilization and Cleaning Validations, Packaging / Transit Validations, Shelf Life Assessment; Biocompatibility Assessment; and Bench Performance Testing, including MR Compatibility Assessment, as well as Simulated Use Testing, demonstrate that the iFuse-TORQ Implant System meets requirements of the product specification for its intended clinical use and is substantially equivalent to the predicate devices.
VIII. SUMMARY OF VERIFICATION AND VALIDATION ACTIVITIES
SI-BONE performed comprehensive Design Verification and Validation Testing to demonstrate the performance of SI-BONE's iFuse-TORQ Implant System for its intended clinical use (Table 2). Sterilization and Cleaning Validations, Packaging / Transit Validations, Shelf-Life Assessment; Biocompatibility Assessment; and Bench Performance Testing, including MR Compatibility Assessment, as well as Simulated Use Testing have been performed.
| Test | Standards |
|---|---|
| Sterilization Validation | SS EN ISO 11137-1:2015 - Sterilization of Health Care Products: Radiation Sterilization - Part 1: Requirements for development, validation, and routine control of a sterilization process for medical devices |
| Sterilization Validation | |
| iFuse-TORQ Implants | SS EN ISO 11137-2:2015 - Sterilization of Health Care Products: Radiation Sterilization - Part 2: Establishing the Sterilization Dose – Method VD-Max 25 SS EN ISO 11137-3:2017 - Sterilization of health care products – Radiation - Part 3: Guidance on Dosimetric aspects of development, validation, and routine control ANSI / AAMI / ISO 11737-1:2018 - Sterilization of medical devices — Microbiological methods, Part 1: Determination of population of microorganisms on products ANSI / AAMI / ISO 11737-2:2019 - Sterilization of medical devices — Microbiological methods, Part 2: Tests of sterility performed in the definition, validation, and maintenance of a sterilization process |
| Sterilization Validation | |
| iFuse-TORQ Instruments | ANSI/AAMI/ISO 17665-1:2006/(R)2013 - Requirements for the Development, Validation and Routine Control of a Sterilization Process for Medical Devices AAMI TIR12-2010 - Designing, testing, and labeling reusable medical device for reprocessing in health care facilities. A guide for medical device manufacturers ANSI/AAMI ST79:2017 - Comprehensive guide to steam sterilization and sterility assurance in health care facilities ANSI/AAMI ST77:2013 - Containment devices for reusable medical device sterilization |
| Cleaning Validation | |
| Cleaning Validation iFuse | |
| TORQ Implants | EN ISO 19227:2018 - Implants for Surgery - Cleanliness of Orthopedic Implants – General Requirements ISO 10993-5:2009 - Biological evaluation of medical devices – Part 5: Tests for in vitro cytotoxicity |
| Cleaning Validation | |
| Assessment iFuse-TORQ | |
| Instruments | AAMI TIR30:2011(R):2016 - A compendium of processes materials, test methods, and acceptance criteria for cleaning reusable medical devices |
| Repeat Cleaning and | |
| Steam Sterilization | |
| Assessment - iFuse- | |
| TORQ Instruments | AAMI TIR12:2010 - Designing, testing, and labeling reusable medical devices for reprocessing in health care facilities: A guide for medical device manufacturers AAMI TIR17:2017 - Compatibility of materials subject to sterilization |
| Packaging Validation | |
| Packaging Validation | |
| iFuse-TORQ Implants | EN ISO 11607-1:2019 - Packaging for terminally sterilized medical devices – Part 1: Requirements for materials, sterile barrier systems and packaging systems ASTM D4332-14 - Standard Practice for Conditioning Containers, Packaging, or Packaging Components for Testing ASTM D4169-16 (Distribution Cycle 13) – Standard Practice for Performance Testing of Shipping Containers and Systems ASTM F2096-11 (2019) - Standards Test Method for Detecting Gross Leaks in Packaging by Internal Pressurization (Bubble Test) ASTM F88-15 – Standard Test Method for Seal Strength of Flexible Barrier Materials |
| Packaging Validation | ASTM D4332-14 - Standard Practice for Conditioning Containers, Packaging, or |
| Test | Standards |
| iFuse-TORQ Instruments | • Packaging Components for Testing |
| ASTM D4169-16 (Distribution Cycle 13) - Standard Practice for Performance Testing of | |
| Shipping Containers and Systems | |
| Shelf Life | |
| Shelf Life Rationale for | |
| iFuse-TORQ Implants | • ASTM F1980-16 – Standard Guide for Accelerated Aging of Sterile Barrier Systems for |
| Medical Devices | |
| Biocompatibility | |
| Assessments | |
| Biological Safety | |
| Evaluation iFuse-TORQ | |
| Implants | • ISO 10993-1:2018 - Biological Evaluation of Medical Devices – Part 1: Evaluation and |
| Testing within a Risk Management Process | |
| Biological Safety | |
| Evaluation iFuse-TORQ | |
| Instruments | • ISO 10993-1:2018 - Biological Evaluation of Medical Devices – Part1: Evaluation and |
| Testing within a Risk Management Process | |
| Bench Performance | |
| Testing - iFuse-TORQ | |
| Implant System - | |
| Implants | |
| Bench Testing iFuse- | |
| TORQ Implant System | • ASTM F543-17 – Standard Specification and Test Methods for Metallic Medical Bone |
| Screws | |
| • ASTM F2193-20 - Standard Specifications and Test Methods for Components Used in the | |
| Surgical Fixation of the Spinal Skeletal System | |
| Elemental Analysis iFuse- | |
| TORQ Implants | • ASTM F3001-14 - Standard Specification for Additive Manufacturing Titanium-6- |
| Aluminum-4 Vanadium ELI (Extra Low Interstitial) with Powder Bed Fusion | |
| Fatigue Testing iFuse- | |
| TORQ Implants | • ASTM F2193-20 - Standard Specifications and Test Methods for Components Used in the |
| Surgical Fixation of the Spinal Skeletal System | |
| Torsion Testing iFuse- | |
| TORQ Implants | • ASTM F543-17 - Standard Specifications and Test Methods for Metallic Medical Bone |
| Screws | |
| Surface Characteristics | |
| and Surface Treatment | |
| Performance iFuse-TORQ | |
| Implants: | |
| Stereological Evaluation | |
| of the Porous Layer | • ASTM F1854-15 - Standard Test Method for Stereological Evaluation of Porous Coatings |
| on Medical Implants | |
| Static Shear Testing | • ASTM F1044-05 (2017) - Standard Test Method for Shear Testing of Calcium Phosphate |
| Coatings and Metallic Coatings | |
| Shear Fatigue Testing | • ASTM F1160-14 (2017) - Standard Test Method for Shear and Bending Fatigue Testing of |
| Calcium Phosphate and Metallic Medical and Composite Calcium Phosphate/Metallic | |
| Coatings | |
| Static Tensile Testing | • ISO 13179-1:2014 - Implants for surgery - Plasma-sprayed unalloyed titanium coatings |
| on metallic surgical implants - Part 1: General requirements | |
| • ASTM F1147-05 (2017) - Standard Test Method for Tension Testing of Calcium | |
| Phosphate and Metallic Coatings | |
| Abrasion Properties | • ASTM F1978-18 - Standard Test Method for Measuring Abrasion Resistance of Metallic |
| Thermal Spray Coatings by Using the Taber Abraser | |
| MR Compatibility | |
| Assessment | • ASTM F2052-15 - Standard Test Method for Measurement of Magnetically Induced |
| Displacement Force on Medical Devices in the Magnetic Resonance Environment | |
| • ASTM F2119-13 - Standard Test Method for Evaluation of MR Image Artifacts from | |
| Passive Implants | |
| • ASTM F2182-19e2 - Standard Test Method for Measurement of Radio Frequency Induced | |
| Heating on or Near Passive Implants During Magnetic Resonance Imaging | |
| • ASTM F2213-06 (2011) - Standard Test Method for Measurement of Magnetically | |
| Induced Torque on Medical Devices in the Magnetic Resonance Environment | |
| • ASTM F2503 -13 - Standard Practice for Marking Medical Devices and Other Items for | |
| Safety in the Magnetic Resonance Environment | |
| Test | Standards |
| Bench Performance | |
| Testing -Instruments | |
| Bench Testing-iFuse- | |
| TORQ | |
| Implant System - | |
| Instruments | • ASTM F543-17 - Standard Specification and Test Methods for Metallic Medical Bone |
| Screws | |
| Navigational Instrument | |
| Positional Error iFuse- | |
| TORQ Instruments | • ASTM F2554-2018 – Standard Practice for Measurement of Positional Accuracy of |
| Computer Assisted Surgical Systems | |
| Navigation Adapter iFuse- | |
| TORQ Instruments | N/A |
| System Validation | |
| Simulated Use Testing | • ANSI/AAMI HE75:2009/(R) 2018 - Human factors engineering - Design of medical |
| devices | |
| • EN 62366: 2008, Medical devices – Application of usability engineering to medical | |
| devices (IEC 62366:2007) | |
| • IEC 62366-1: 2015 - Medical devices - Part 1: Application of usability engineering to | |
| medical devices |
Table 2. Design Verification and Validation Testing
7
8
IX. CONCLUSION
The SI-BONE iFuse-TORQ Implant System has the same intended use, similar indications for use and technological characteristics as the FDA cleared Medacta International M.U.S.T. Sacral Iliac Screw and Pelvic Trauma System (most recently cleared in K193083 and K171595). The iFuse-TORQ Implant is fabricated from similar materials, manufactured using similar processes, and utilizes similar cleaning and identical sterilization processes as the SI-BONE iFuse-3D Implant (most recently cleared in K193524 and in K162733).
Verification and validation testing provided in the subject premarket notification demonstrates that the iFuse-TORQ Implant System meets the requirements of the product specification for its intended clinical use and is substantially equivalent to the predicate devices.